Daraxonrasib Breakthrough for Pancreatic Cancer | Phoenix News

FDA just approved Daraxonrasib, a groundbreaking daily pill that’s slashing pancreatic cancer deaths by nearly doubling survival time—working in 90% of cases by targeting the root cause. Developed fast thanks to stellar results, it’s hailed as the first true targeted therapy for this deadly disease and could unlock new treatments for other cancers too. Doctors and nurses are buzzing with hope, seeing this as just the beginning of a future where curing cancer might be possible. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/17a9f2c430b1fc6a